Why Australia

Reduce your development timelines.

Australia has the global reputation of helping sponsors accelerate their early phase development by reducing cash-burn and reducing approval timelines relative to other major jurisdictions.

When coupled with the ability to avoid an IND, by considering Australia in early phase development, sponsors are able to extend their development funds and save anywhere from 6 to 12 months from your Phase I timelines. When coupled with the ability to collect participant data sooner that other jurisdictions, and major regulators accepting Australian data, Australia becomes an ideal destination for clinical trials.

Key Advantages

There are many benefits to running your clinical trial in Australia, we have:

Some of the best and brightest researchers and health professionals in the world;
A research infrastructure that is world class and conducive to clinical research
One of the most stable socio-political environments in the world;
The highest of clinical and ethical standards ensuring confidence in the outcomes and results generated by clinical trials conducted in Australia, aligned to ICH GCP standards;
An exceptionally low risk of Intellectual Property theft, due to our robust and globally aligned IP protection systems;
One of the most favourable, and efficient regulatory approval processes in the world;
Opposing seasons: Seasonal differences between the northern and southern hemispheres allow trials to be conducted or continued in Australia, extending periods for patient recruitment. Examples include clinical trials for flu vaccines, allergy or respiratory diseases.

Strength in diversity

Australia is one of the most multicultural countries across the entire South East Asian region and has:

A diverse population that can meet recruitment needs, but also recruit specific cohorts as part of ethno-bridging studies;
An informed and highly engaged general population that is enthusiastic about participation in clinical trials;
A much higher level of research engagement and participation than would be expected based on a country of our size.

Australian clinical practices and some aspects of its healthcare system are similar to the United States, Canada and most European countries and our diverse population means researchers can recruit a similar patient population to those countries.

Why Australia

Reduce your development timelines.

Australia has the global reputation of helping sponsors accelerate their early phase development by reducing cash-burn and reducing approval timelines relative to other major jurisdictions.

Key Advantages

Strength in diversity

Sponsors

Participants

Contact Us

Express Interest Japanese studies

임상 연구에 관심이 있는 한국 과목